Superior Uniform Group, Inc. Reports Operating Results for 2015
Feb 25, 2016 12:00 pm UTC| Business
Net Sales Increase 7.2% Net Income Increases 15.1%Earnings per share (Diluted) Increases 9.8% SEMINOLE, Fla., Feb. 25, 2016 -- Superior Uniform Group, Inc. (NASDAQ:SGC), manufacturer of uniforms, image apparel and...
CyberC4:Alert From Kratos’ RT Logic Receives NIAP Certification
Feb 25, 2016 12:00 pm UTC| Business
SAN DIEGO, Feb. 25, 2016 -- Kratos Defense Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, announced today that CyberC4®:Alert, a product from its RT Logic subsidiary, has been...
Cloudera Contributing to President’s Precision Medicine Initiative
Feb 25, 2016 12:00 pm UTC| Business
Washington, D.C., Feb. 25, 2016 -- Precision medicine promises to revolutionize healthcare: to improve diagnosis, to target treatment, and to deliver better care. Living up to that promise requires collaboration and...
Anavex Presents Preclinical Results of ANAVEX 2-73 in Rett Syndrome
Feb 25, 2016 12:00 pm UTC| Business
- Data presentation at 2016 Epilepsy Pipeline Conference - - Company exploring potential to advance ANAVEX 2-73 into human clinical studies in rare disease indication - NEW YORK, Feb. 25, 2016 -- Anavex Life Sciences...
MiT National Land Services Names Stephanie Lenti Vice President of Business Development
Feb 25, 2016 12:00 pm UTC| Business
NEW YORK, Feb. 25, 2016 -- MiT National Land Services (MiT), a large title insurance agency focused on both commercial and residential properties, today announced that former Lincoln Land senior sales executive...
Plug Power to Announce 2015 Fourth Quarter and Year End Results on March 10, 2016
Feb 25, 2016 12:00 pm UTC| Business
LATHAM, N.Y., Feb. 25, 2016 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing clean, reliable energy solutions, today confirms it will release the Company’s 2015 fourth quarter and year end results on March 10,...
Heat Biologics Provides Update on Its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm
Feb 25, 2016 12:00 pm UTC| Business
No longer enrolling new patients in monotherapy trial arm due to the current availability of standard of care BCGNo safety concerns related to HS-410; all enrolled patients receiving HS-410 will continue treatment DURHAM,...